Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy

Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy

Abstract Background Expression of PD-L1 is the most investigated predictor of benefit from immune checkpoint blockade in advanced NSCLC but little is known about the association of PD-L1 expression and clinicopathological parameters of patients with unresectable stage III NSCLC. Methods National reg...

Full description

Bibliographic Details
Main Authors: Martina Vrankar, Izidor Kern, Karmen Stanic
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Radiation Oncology
Subjects:
Non small cell lung cancer
PD-L1 expression
Stage III
Chemoradiotherapy
Online Access:http://link.springer.com/article/10.1186/s13014-020-01696-z

Internet

http://link.springer.com/article/10.1186/s13014-020-01696-z

Similar Items